Risk of Secondary Malignant Neoplasms From Proton Therapy and Intensity-Modulated X-Ray Therapy for Early-Stage Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 2, 2009, Pages 616-622

  Fontenot, Jonas D ^a,b   Lee, Andrew K ^a   Newhauser, Wayne D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MARY BIRD PERKINS CANCER CENTER   (United States)

Author keywords

Intensity modulated X ray therapy; Prostate cancer; Proton therapy; Second cancers

Indexed keywords

BIOLOGICAL EFFECTS OF IONIZING RADIATIONS; IN FIELDS; INTENSITY-MODULATED RADIATION THERAPIES; INTENSITY-MODULATED X-RAY THERAPY; MEASURED DATUM; MONTE CARLO SIMULATIONS; ORGANS AT RISKS; PROSTATE CANCER; PROTON THERAPY; RISK MODELS; SECOND CANCERS; SECONDARY RADIATIONS; THERAPEUTIC BEAMS; TREATMENT PLANS;

BIOLOGICAL ORGANS; MONTE CARLO METHODS; PHYSICAL THERAPY; PROTON BEAMS; PROTONS; RADIATION EFFECTS; RISK MANAGEMENT; RISK PERCEPTION; TUMORS; X RAYS;

RISK ASSESSMENT;

ADULT; ARTICLE; BLADDER; CANCER RISK; CASE REPORT; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IONIZING RADIATION; MALE; MATHEMATICAL MODEL; MONTE CARLO METHOD; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTON THERAPY; RADIATION DOSE; RECTUM; SECOND CANCER; TREATMENT PLANNING; X RAY;

ADENOCARCINOMA; ALGORITHMS; HUMANS; MALE; MIDDLE AGED; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROSTATIC NEOPLASMS; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SCATTERING, RADIATION;

EID: 65449143495     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.01.001     Document Type: Article

References (30)

1. Baxter N.N., Tepper J.E., Durham S.B., et al. Increased risk of rectal cancer after prostate radiation: A population-based study. Gastroenterology 128 (2005) 819-824
2. Brenner D.J., Curtis R.E., Hall E.J., et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88 (2000) 398-406
3. Moon K., Stukenborg G.J., Keim J., et al. Cancer incidence after localized therapy for prostate cancer. Cancer 107 (2006) 991-998
4. Kry S.F., Salehpour M., Followill D.S., et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 1204-1216
5. Mock U., Georg D., Bogner J., et al. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 58 (2004) 147-154
6. Trofimov A., Nguyen P.L., Coen J.J., et al. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: A treatment planning comparison. Int J Radiat Oncol Biol Phys 69 (2007) 444-453
7. Schneider U., Lomax A., Besserer J., et al. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 892-897
8. Schneider U., Lomax A., Pemler P., et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 182 (2006) 647-652
9. Koehler A., Schneider R., and Sisterson J. Flattening of proton dose distributions for large-field radiotherapy. Med Phys 4 (1977) 297-301
10. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
11. Hall E.J. The impact of protons on the incidence of second malignancies in radiotherapy. Technol Cancer Res Treat 6 (2007) 31-34
12. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP 21 (1991) 1-201
13. Zhang X., Dong L., Lee A.K., et al. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys 67 (2007) 620-629
14. Smith A., Newhauser W., Latinkic M., et al. The University of Texas MD Anderson Cancer Center Proton Therapy Center. In: Duggan J., and Morgan I. (Eds). 17th International Conference on the Application of Accelerators in Research and Industry (2002), American Institute of Physics, Denton, TX 1073-1076
15. Slater J.D., Yonemoto L.T., Rossi Jr. C.J., et al. Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 42 (1998) 299-304
16. Newhauser W., Zheng Y., Taddei P., et al. Monte Carlo proton radiation therapy planning calculations. Trans Am Nuc Soc 99 (2008) 63-64
17. Fontenot J.D., Taddei P., Zheng Y., et al. Organ equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancer. Phys Med Biol 53 (2008) 1677-1688
18. Zheng Y., Fontenot J., Taddei P., et al. Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit. Phys Med Biol 53 (2008) 187-201
19. Mutic S., and Klein E.E. A reduction in the AAPM TG-36 reported peripheral dose distributions with tertiary multileaf collimation. American Association of Physicists in Medicine Task Group 36. Int J Radiat Oncol Biol Phys 44 (1999) 947-953
20. Stovall M., Blackwell C.R., Cundiff J., et al. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys 22 (1995) 63-82
21. Howell R.M., Hertel N.E., Wang Z., et al. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Med Phys 33 (2006) 360-368
22. BEIR VII. Health risks from exposure to low levels of ionizing radiation (2006), National Research Council of the National Academies, Washington D.C.
23. Hall E.J., and Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis. Int J Radiat Biol 80 (2004) 327-337
24. Taddei P., Fontenot J.D., Zheng Y., et al. Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer. Phys Med Biol 53 (2008) 2131-2147
25. Brenner D.J., and Hall E.J. Secondary neutrons in clinical proton radiotherapy: A charged issue. Radiother Oncol 86 (2008) 165-170
26. Vargas C., Fryer A., Mahajan C., et al. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 744-751
27. Schneider U., Zwahlen D., Ross D., et al. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 61 (2005) 1510-1515
28. Moyers M., Benton E., Ghebremedhin A., et al. Leakage and scatter radiation from a double scattering based proton beamline. Med Phys 35 (2008) 128-144
29. Wroe A., Rosenfeld A., and Schulte R. Out-of-field dose equivalents delivered by proton therapy of prostate cancer. Med Phys 34 (2007) 3449-3456
30. Kellerer A.M., Ruhm W., and Walsh L. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors. Health Phys 90 (2006) 554-564